This Week
The Developments
Announced
FTC warns 24 large healthcare companies that incomplete prices may be deceptive
Announced Oct 5, 2026
What changed
The FTC said Chairman Andrew Ferguson sent warning letters to 24 of the nation's largest healthcare services companies. The template letter says timely, accurate and complete pricing for non-emergency, scheduled care is a material term, that omitted or partial prices (for example missing physician or facility fees) can be deceptive or unfair under Section 5 of the FTC Act, and that complying with CMS price transparency rules is a floor, not a safe harbor. The letters are not findings of violation and set no stated deadline.
Why it matters
This adds a second federal enforcement lever to hospital price disclosure beyond CMS's own rules. It is a warning, not an enforcement action; no recipients were named in the sources reviewed, and outcomes depend on whether the FTC follows with cases.
Warrants deeper follow-up. Watch for named recipients, any FTC complaints, and how this interacts with CMS hospital price transparency penalties.
Sources
Background from our research
Storylines
Announced
CMS publishes 2027 Medicare Advantage and Part D Star Ratings
Announced Oct 8, 2026; open enrollment Oct 15 – Dec 7; affects 2028 bonus payments
What changed
CMS released the 2027 Star Ratings. Per its fact sheet, about 71% of Medicare Advantage drug-plan enrollees are in plans rated four or more stars and 15 contracts earned five stars. Methodology changes include two new measures (concurrent opioid and benzodiazepine use, and polypharmacy), the return of the functional status assessment, a respecified colorectal cancer screening measure, and higher weights for physical and mental health outcome measures. The ratings feed 2028 quality bonus payments.
Why it matters
Star Ratings steer enrollment during open enrollment and determine bonus payments to plans. This release does not evaluate whether the ratings track care quality. The headline share of enrollees in high-rated plans is CMS's own calculation.
Sources
Background from our research
Storylines
Proposed
House Democrat proposes replacing No Surprises Act arbitration with benchmark payments; physician groups object
Introduced Oct 8, 2026
What changed
Rep. Frank Pallone (D-N.J.) introduced the Lower Premiums, Faster Payments Act. As reported by Fierce Healthcare, it would replace the No Surprises Act independent dispute resolution (IDR) process for out-of-network payment disputes with market-based benchmarks tied to median in-network rates, and require payment within 30 days of a claim. On Oct. 8 the American Society of Anesthesiologists, American College of Emergency Physicians and American College of Radiology issued a statement opposing it. No committee action has been reported.
Why it matters
Payers call the current arbitration system broken and costly while providers blame low initial payer offers and slow payments; the bill signals one legislative approach, and the physician statement is advocacy from an affected industry. This is an introduced bill with no scheduled action, not law.
Sources
Background from our research
Storylines
Report
RAND expert panel finds no Medicare Advantage reform that benefits patients, government and plans alike
Health Affairs, October 2026 issue
What changed
A RAND Delphi study in the October issue of Health Affairs, led by Dmitry Khodyakov, surveyed a panel of experts (52 recruited; 37 completed the second round) on a set of Medicare Advantage reform proposals. As reported by Managed Healthcare Executive and Fierce Healthcare, no proposal was rated beneficial to more than one of three groups (beneficiaries, the federal government, plans). The reforms judged most likely near term were standardizing supplemental benefits, limiting the number of plans an insurer can market, and reforming agent commissions; the authors describe these as incremental and say substantial savings would need changes such as competitive bidding and risk-score reform.
Why it matters
It maps the trade-offs behind Medicare Advantage reform and the limited room for consensus. It is an expert-opinion exercise, not evidence on outcomes. This summary relies on trade-press coverage because the journal page could not be opened, and the outlets disagree on the number of proposals rated, so no count is given.
Sources
Background from our research
Storylines